Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study-Reference-Cited by-同舟云学术

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

Published:2021-03-11 Issue:2 Volume:41 Page:199-206
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharmacol Rep

Author:

Numata Shusuke¹,Nakataki Masahito¹,Hasegawa Naomi²,Takaesu Yoshikazu³,Takeshima Masahiro⁴,Onitsuka Toshiaki⁵,Nakamura Toshinori⁶,Edagawa Reon¹,Edo Hiroaki¹,Miura Kenichiro²^ORCID,Matsumoto Junya²^ORCID,Yasui‐Furukori Norio⁷^ORCID,Kishimoto Taishiro⁸,Hori Hikaru⁹,Tsuboi Takashi³,Yasuda Yuka²¹⁰,Furihata Ryuji¹¹¹²,Muraoka Hiroyuki¹³,Ochi Shinichiro¹⁴,Nagasawa Tatsuya¹⁵,Kyou Yoshitaka¹⁶,Murata Atsunobu²,Katsumoto Eiichi¹⁷,Ohi Kazutaka¹⁸,Hishimoto Akitoyo¹⁹,Inada Ken¹³^ORCID,Watanabe Koichiro³,Hashimoto Ryota²^ORCID

Affiliation:

1. Department of Psychiatry Institute of Biomedical Science Tokushima University Graduate School Tokushima Japan

2. Department of Pathology of Mental Diseases National Center of Neurology and Psychiatry National Institute of Mental Health Tokyo Japan

3. Department of Neuropsychiatry School of Medicine Kyorin University Tokyo Japan

4. Department of Neuropsychiatry Akita University Graduate School of Medicine Akita Japan

5. Department of Neuropsychiatry Graduate School of Medical Sciences Kyushu University Fukuoka Japan

6. Department of Psychiatry Shinshu University School of Medicine Nagano Japan

7. Department of Psychiatry School of Medicine Dokkyo Medical University Tochigi Japan

8. Department of Neuropsychiatry Keio University School of Medicine Tokyo Japan

9. Department of Psychiatry School of Medicine University of Occupational and Environmental Health Fukuoka Japan

10. Medical Corporation Foster Osaka Japan

11. Department of Psychiatry Nihon University School of Medicine Tokyo Japan

12. Kyoto University Health Service Kyoto Japan

13. Department of Psychiatry Tokyo Women’s Medical University Tokyo Japan

14. Department of Neuropsychiatry, Molecules and Function Ehime University Graduate School of Medicine Ehime Japan

15. Department of NeuroPsychiatry Kanazawa Medical University Ishikawa Japan

16. Department of Psychiatry School of Medicine Kitasato University Kanagawa Japan

17. Katsumoto Mental Clinic Osaka Japan

18. Department of Psychiatry and Psychotherapy Gifu University Graduate School of Medicine Gifu Japan

19. Department of Psychiatry Yokohama City University Graduate School of Medicine Yokohama Japan

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12173

Reference19 articles.

1. National Institute for Health and Clinical Excellence (NICE).The treatment and management of depression in adults (updated edition)‐National Clinical Practice Guideline.2010.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public preferences and willingness to pay for a net zero NHS: a protocol for a discrete choice experiment in England and Scotland;BMJ Open;2024-06

2. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan;BMJ Open;2024-06

3. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study;BMC Psychiatry;2024-05-29

4. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project;Psychiatry Research Communications;2024-03

5. Financial conflicts of interest and disclosure in clinical practice guidelines for bipolar disorder and major depressive disorder in Japan;2023-11-10